WITH THE CORONAVIRUS vaccine hurtling toward its public debut as early as late fall, the United States is about to enter a new and precarious phase of the pandemic response. Regardless of when a vaccine becomes available, the rollout is almost destined to be messy for logistical reasons, as public-health officials must ready a massive campaign to convince 330 million citizens to take it. But after months of misinformation and disingenuous optimism from the White House—underlined by revelations that President Trump knew all along that the coronavirus is deadly—will anyone trust the administration’s assurances about the new vaccine’s safety?
There are already clear signs that the public is suspicious about the rigor with which a vaccine will have been assessed before its release, and experts are increasingly concerned that conflicting information about who should be immunized, and when, will further erode public confidence. A recent CBS News poll indicated that only 21 percent of Americans would be inclined to take a COVID-19 vaccine as soon as possible, while 62 percent expressed concern that the Trump administration is pressuring the Food and Drug Administration to relax safety and efficacy standards to rush out a vaccine, according to a survey conducted by the Kaiser Family Foundation.
This public distrust has likely been fueled by continued hints from the president that a vaccine might be available before Election Day—a timeline most experts believe is unfeasible without a short circuit of the normal vetting process. That could include authorizing a vaccine before Phase 3 clinical trials are complete or marginalizing the input of the FDA’s independent vaccine advisory committee. While the Centers for Disease Control and Prevention recently notified state and local health officials to be prepared to distribute potential vaccines as soon as late October, as the New York Times reported, many public-health experts are skeptical about what even the CDC has labeled a “hypothetical” scenario. “It would be surprising if we had statistically robust evidence for this vaccine working by the end of October,” says Paul Offit, a vaccine expert at the University of Pennsylvania School of Medicine and a member of the FDA advisory panel.
Continue reading your story on the app
Continue reading your story in the magazine
While You Were Truly Out
WHAT I WANT OUT OF OFFICE gossip is what Herman Melville delivers in “Bartleby, the Scrivener,” Ur-text of Manhattan office life. Imagine hearing it over happyhour beers some Thursday night.
The National Interest: Jonathan Chait
100 Days That Reshaped America Learning from Joe Biden’s quiet, seismic young presidency.
The End of Kimye's Wild Ride
She thought he was an artistic genius. He wanted to “dip her ass in gold.” And now it’s over.
Dancing on Your Own (Together)
A temporary club for an in-between moment.
Mads Mikkelsen – ‘Oh, That's Right. I'm This Guy.'
Mads Mikkelsen is known for playing villains in America and more nuanced roles in Denmark. He takes everything and nothing seriously.
India Off the Beaten Path
For their latest venture, Dhamaka, the owners of Queens hit Adda delve deeply into the country’s most local pleasures.
Their First Apartment Together Launched a Small Business
Just out of NYU, David Zhang and Sarah Kim turned their Bushwick rental into a home-furnishings lab.
30 minutes with … Eric Adams
Eight weeks before the mayoral primary and second in the polls, Brooklyn’s borough president sharpens his case for more cops.
The System: Zak Cheney-Rice
We’ll Be Here Again Chauvin’s verdict is self-preservation disguised as redemption.
Daniel Dae Kim built a career by picking his battles, walking away from a job only when the inequities got too big to ignore. He still believes Hollywood can be reformed.
The LAST PANDEMIC
TECHNOLOGICAL BREAKTHROUGHS AND POLICY PROGRESS MEAN HUMANITY MAY NEVER AGAIN HAVE TO ENDURE A DISASTER LIKE COVID-19.
AIRLINES PUSH WHITE HOUSE TO REJECT TESTING FOR US FLIGHTS
Leaders of several major U.S. airlines met online with White House officials to press their case against requiring coronavirus tests for passengers on domestic flights, saying it would undermine the already fragile industry.
COPING WITH THE LOSS OF Home for the Holidays
A wise man once wrote, there’s no place like home for the holidays, but this year, unfortunately that’s not the case. With the CDC recommending that we don’t head home this holiday season, the typically joyous time of year that we could all really use has to be put on pause.
HOW DO I KNOW WHEN TO GET MY 2ND VACCINE SHOT?
As U.S. health officials try to get COVID-19 vaccines to people more quickly, it’s already time for some people to get their second shots.
Screening, Vaccinations Help Fight Cervical Cancer
January is Cervical Health Awareness Month and an important time of year to raise awareness about the importance of cervical health screenings for women.
IS IT SAFE TO STAY IN HOTELS DURING THE PANDEMIC?
Is it safe to stay in hotels during the pandemic?
KEEP YOUR EYES HEALTHY DURING THE COVID PANDEMIC
During the coronavirus pandemic, people should guard their eyes with glasses or face shields to protect their eyes from virus infection.
UF/IFAS Extension Helps Farmworkers Stay Safe From COVID
UF/IFAS EXTENSION EXPERTS are communicating with agricultural workers to connect them with COVID-19 free testing, safety information and training – a role they have been serving throughout the pandemic.
WE CAN STILL PASS THIS TEST
With the seasons changing and a vaccine a ways off, the U.S. needs to dramatically improve its infrastructure for rapid Covid testing. It’s got options
HIGH DEMAND FOR FLU SHOTS? EXPERTS HOPE TO AVOID ‘TWINDEMIC'
October is prime time for flu vaccinations, and the U.S. and Europe are gearing up for what experts hope is high demand as countries seek to avoid a “twindemic” with COVID-19.